RNS Number : 2909V
3i Infrastructure PLC
01 December 2023
 

 

 

3i Infrastructure plc completes the sale of its stake in Attero and announces further investment in Future Biogas

1 DECEMBER 2023

3i band 8mm midblue RGB

3i Infrastructure plc ("3i Infrastructure" or "the Company") yesterday completed the sale of its c.25% stake in Attero, one of the largest waste treatment and recycling companies in the Netherlands. The sale, to Ardian, was announced on 24 July 2023.

The net sale proceeds of ?215m will be used to partially repay drawings on 3i Infrastructure's revolving credit facility.

Also on 30 November, the Company completed a further investment of £30 million in Future Biogas to fund the acquisition of two anaerobic digestion plants which are currently operated by Future Biogas. This acquisition is in line with our strategy to grow Future Biogas into a leading developer, asset owner and operator of green gas plants in the UK.

 

-ENDS-

 

 

 

For further information, contact:

 

Thomas Fodor

Investor enquiries

 

Kathryn van der Kroft

Media enquiries

 

 

Tel: +44 20 7975 3469

Email: thomas.fodor@3i.com

 

Tel: +44 20 7975 3021

Email: kathryn.vanderkroft@3i.com

 

 

 

 

 

 

Notes to editors:

 

3i Infrastructure plc

 

3i Infrastructure plc is a Jersey-incorporated, closed-ended investment company, an approved UK Investment Trust, listed on the London Stock Exchange and regulated by the Jersey Financial Services Commission. The Company's purpose is to invest responsibly in infrastructure, delivering long-term sustainable returns to shareholders and having a positive influence on our portfolio companies and their stakeholders.

 

3i Investments plc, a wholly-owned subsidiary of 3i Group plc, is authorised and regulated in the UK by the Financial Conduct Authority and is the investment manager to 3i Infrastructure plc.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCDBLFXXFLLFBQ